Novel PET Imaging in Prostate Cancer

Evan Y. Yu, MD, associate professor, Department of Medicine, Division of Oncology, Seattle Cancer Care Alliance, discusses the role of PET imaging in prostate cancer.

Clinical Pearls:

• Various types of PET imaging can be used to help detect prostate cancer and measure prostate cancer treatment responses
• A study that explored sodium fluoride PET as a marker in treatment response with dasatinib showed a longer progression-free survival
• PET imaging showed that ARN-509 was hitting its intended target and helped researchers determine the optimal biologic dosing for the agent
• Using PET imaging in clinical trials will help researchers get a better understanding the mechanism of action of some novel agents